Microfluidic chip device for multi-channel simultaneous detection of six typical tumor markers

Abstract

The invention relates to a microfluidic chip device for multi-channel simultaneous detection of six typical tumor markers, and belongs to the field of analysis and testing. Polydimethylsiloxane, i.e. PDMS, is used for preparing a substrate of the microfluidic chip for multi-channel combined detection of six typical tumor markers, which has obvious advantages but also has a series of challenges. Aiming at the series of challenges, the invention is provided. The key points of the invention are as follows: the PDMS with an original form surface is selected as the substrate; a micro ultrasonic transducer is attached to a position adjacent to a sample liquid flow terminal of the microfluidic chip; and meanwhile, the sample injection end of the microfluidic chip is provided with an ultrasonic attenuator, so that the ultrasonic strength quickly descends within a short distance, an interfacial tension difference is thus formed between the two ends of the chip, the interfacial tension difference causes a pressure difference between the two ends, and the pressure difference drives a liquid flow to flow towards the terminal along an original high-hydrophobicity pipeline.

Description

technical field [0001] The invention relates to a microfluidic chip device for multi-channel simultaneous detection of six typical tumor markers, which belongs to the field of analysis and testing. Background technique [0002] Tumor markers (tumor markers, TM) refer to a class of substances produced by tumor cells themselves or produced by the body's response to tumor cells during the occurrence and proliferation of tumors, reflecting the existence and growth of tumors, including Proteins, hormones, enzymes (isoenzymes) and oncogene products, etc. Testing the tumor markers in the patient's blood or body fluids can detect tumors early in the tumor screening, observe the curative effect of tumor treatment and judge the prognosis of patients. Currently, the tumor markers commonly used clinically are: (1) alpha-fetoprotein (AFP) is a marker for primary liver cancer, testicular cancer, ovarian cancer and other tumors; (2) carcinoembryonic antigen (CEA) is a marker for digestive...

AI Technical Summary

Problems solved by technology

[0008] But it's not that simple

[0009] First, this polydimethylsiloxane material, the material referred to by the acronym PDMS, is itself a strongly hydrophobic material. Microchannels are built on this material. If the microchannels are not targeted The modification operation of the surface of the channel, then, after the overall assembly is completed, that is, after the cover is covered, because the inner surface of the micro channel in the structure occupies most of the inner surface of the liquid flow channel, then the PDMS micro channel The strong hydrophobic characteristic of the inner surface of the channel is the decisive factor, which will make it very difficult for the polar liquid flow similar to the aqueous solution to pass through, and its flow resistance is so large that even ordinary micropumps are difficult to push. Of course, If the cover sheet also chooses to use the PDMS material, then the problem is basically the same, with little difference; therefore, in the prior art, it is necessary to modify and modify the inner surface of the microchannel on the PDMS material; then , is this modification operation for the inner surface of the PDMS microchannel very troublesome? That's not the problem. What constitutes a serious technical problem i

Images